AKTX

AKARI THERAPEUTICS PLC

AKTX·00972G207·US·ADR·Healthcare - Biotechnology-Activist

AKTX (AKARI THERAPEUTICS PLC) is held by 0 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($5). Net institutional sentiment: Bearish.

0
Holders
(3 Elite)
$0
Total Value
0% (9)
Consensus
0 buying - 9 selling
13F: Insider & Congress:
AKTXSmart Money Verdict
View all
Held by 0 funds
3 elite
Who's Trading
ActivistMIMMCAP International Inc. SPC8.0%Jun 8, 2026
ActivistRPRay Prudo, M.D.8.9%Mar 4, 2026
ActivistHHHoyoung Huh, M.D., Ph.D.18.4%Mar 4, 2026
ActivistSRSamir R. Patel10.4%Mar 4, 2026
InsiderGAGaslightwala AbizerBuy $3KAug 25, 2025
InsiderGAGaslightwala AbizerBuy $7KAug 22, 2025
InsiderGAGaslightwala AbizerBuy $9KAug 21, 2025
InsiderGAGaslightwala AbizerBuy $6KJun 24, 2025
InsiderGAGaslightwala AbizerBuy $1KJun 23, 2025
InsiderGAGaslightwala AbizerBuy $12KJun 20, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Exited
0(-100.0%)$237,6930.0%+5934.78%
0
New
1$50.0%+5934.78%
17
Exited
0(-100.0%)$1180.0%-57.18%
0
Exited
0(-100.0%)$14,1660.0%-14.81%
0
Exited
0(-100.0%)$22,8990.0%-80.17%
0
Exited
0(-100.0%)$1,9650.0%-80.17%
0
Exited
0(-100.0%)$20,7050.0%-14.81%
0
Exited
0(-100.0%)$9,4960.0%-15.32%
0
Exited
0(-100.0%)$6,8330.0%-93.03%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used